Compare
Calidi Biotherapeutics, Inc. vs Greenland Mines Ltd vs Dyadic International Inc vs VivoSim Labs, Inc.
| Latest fiscal year | Calidi Biotherapeutics, Inc. CLDI | Greenland Mines Ltd GRML | Dyadic International Inc DYAI | VivoSim Labs, Inc. VIVS |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2025-12-31 | 2026-03-31 |
| Revenue | n/a | n/a | $3.09M | $131.0K |
| Revenue growth (YoY) | n/a | n/a | -11.6% | -9.0% |
| Gross margin | n/a | n/a | 24.9% (computed) | n/a |
| Operating margin | n/a | n/a | -232.8% | n/m |
| Net margin | n/a | n/a | -238.3% | n/m |
| Net income | -$19.91M | -$10.55M | -$7.36M | -$13.84M |
| EPS (Diluted) | -$5.95 | -$0.22 | -$0.23 | -$5.35 |
| Operating cash flow | -$21.29M | -$5.89M | -$5.70M | -$10.83M |
| Free cash flow | n/a | n/a | n/a | -$10.83M |
| Cash & equivalents | n/a | $7.18M | $4.62M | $5.02M |
| Total assets | $8.86M | $9.59M | $9.95M | $7.39M |
| Total liabilities | $5.10M | $129.8K | $8.71M | $8.48M |
| Shareholders' equity | $3.76M | $9.46M | $1.23M | -$1.10M |
| Return on year-end equity | -529.6% | -111.5% | -597.6% | n/a |
| Shares outstanding | 7.22M | 72.54M | 36.19M | 2.89M |
Revenue, most recent five fiscal years
| Fiscal year | Calidi Biotherapeutics, Inc. | Greenland Mines Ltd | Dyadic International Inc | VivoSim Labs, Inc. |
|---|---|---|---|---|
| Latest | $45.0K Ended 2022-12-31 | n/a | $3.09M Ended 2025-12-31 | $131.0K Ended 2026-03-31 |
| 1 year earlier | n/a | n/a | $3.50M Ended 2024-12-31 | $144.0K Ended 2025-03-31 |
| 2 years earlier | n/a | n/a | $2.90M Ended 2023-12-31 | $109.0K Ended 2024-03-31 |
| 3 years earlier | n/a | n/a | $2.93M Ended 2022-12-31 | $370.0K Ended 2023-03-31 |
| 4 years earlier | n/a | n/a | $2.40M Ended 2021-12-31 | $1.50M Ended 2022-03-31 |